Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly pentosan polysulfate injections in adults with Mucopolysaccharidosis Type I on enzyme replacement therapy
2014-000350-11Phase 2Completed
- Sponsor
- Multiplex Pharma Holdings
- Start
- Mar 2014
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pentosan polysulfate sodium in mucopolysaccharidosis type I (2 arms), sponsored by Multiplex Pharma Holdings. Primary endpoint: Safety. Started Mar 2014; status: completed.
02
Drugs
pentosan polysulfate sodium
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on 2014-000350-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000350-11.